Skip to main content
Erschienen in: Reactions Weekly 1/2012

01.08.2012 | Case report

Azacitidine/vorinostat

Sweet's syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Pang A, Tan KB, Aw D, Hsieh WS, Goh BC, Lee SC.A case of Sweet's syndrome due to 5-Azacytidine and vorinostat in a patient with NK/T cell lymphoma. Cutaneous and Ocular Toxicology 31: 64-6, No. 1, Mar 2012 - Singapore Pang A, Tan KB, Aw D, Hsieh WS, Goh BC, Lee SC.A case of Sweet's syndrome due to 5-Azacytidine and vorinostat in a patient with NK/T cell lymphoma. Cutaneous and Ocular Toxicology 31: 64-6, No. 1, Mar 2012 - Singapore
Metadaten
Titel
Azacitidine/vorinostat
Sweet's syndrome: case report
Publikationsdatum
01.08.2012
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214140-00040

Weitere Artikel der Ausgabe 1/2012

Reactions Weekly 1/2012 Zur Ausgabe

Case report

Olanzapine

Case report

Clozapine